| [1] |
HOLDEN B A, FRICKE T R, WILSON D A, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050[J]. Ophthalmology, 2016, 123(5): 1036-1042.
|
| [2] |
GRZYBOWSKI A, KANCLERZ P, TSUBOTA K, et al. A review on the epidemiology of myopia in school children worldwide[J]. BMC Ophthalmol, 2020, 20(1): 27.
|
| [3] |
WILLIAMS K M, HAMMOND C J. Perspectives on genetic and environmental factors in myopia, its prediction, and the future direction of research[J]. Invest Ophthalmol Vis Sci, 2025, 66(7): 4.
|
| [4] |
XU R, ZHENG J, LIU L, et al. Effects of inflammation on myopia: evidence and potential mechanisms[J]. Front Immunol, 2023, 14: 1260592.
|
| [5] |
LIN H J, WEI C C, CHANG C Y, et al. Role of chronic inflammation in myopia progression: clinical evidence and experimental validation[J]. EBioMedicine, 2016, 10: 269-281.
|
| [6] |
YUAN J, WU S, WANG Y, et al. Inflammatory cytokines in highly myopic eyes[J]. Sci Rep, 2019, 9(1): 3517.
|
| [7] |
XIN J, BAO B, LIU J, et al. Crosstalk between myopia and inflammation: a mini review[J]. Int J Med Sci, 2024, 21(9): 1589-1603.
|
| [8] |
HUANG Z, ZHOU J, LIU S, et al. The interplay between systemic inflammation and myopia: a bidirectional Mendelian randomization and experimental validation study[J]. Int Immunopharmacol, 2025, 157: 114803.
|
| [9] |
KANG Y T, ZHUANG Z H, HE X, et al. Mendelian randomization supports causal effects of inflammatory biomarkers on myopic refractive errors[J]. Eur J Ophthalmol, 2025, 35(2): 400-408.
|
| [10] |
LONG Q, YE J, LI Y, et al. C-reactive protein and complement components in patients with pathological myopia[J]. Optom Vis Sci, 2013, 90(5): 501-506.
|
| [11] |
HAN S B, JANG J, YANG H K, et al. Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI)[J]. PLoS One, 2019, 14(1): e0211204.
|
| [12] |
ICEL E, UCAK T, KARAKURT Y, et al. The relation of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with high axial myopia[J]. Ocul Immunol Inflamm, 2020, 28(3): 396-401.
|
| [13] |
WANG X, HE Q, ZHAO X, et al. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with high myopia[J]. BMC Ophthalmol, 2022, 22(1): 464.
|
| [14] |
YE S, HOU X, SONG K, et al. Association between dietary inflammatory index and adolescent myopia based on the National Health and Nutrition Examination Survey[J]. Sci Rep, 2024, 14(1): 28048.
|
| [15] |
YU Q, WANG C, LIU Z, et al. Association between inflammatory cytokines and oxidative stress levels in aqueous humor with axial length in human myopia[J]. Exp Eye Res, 2023, 237: 109670.
|
| [16] |
DE PIANO M, CACCIAMANI A, BALZAMINO B O, et al. Biomarker signature in aqueous humor mirrors lens epithelial cell activation: new biomolecular aspects from cataractogenic myopia[J]. Biomolecules, 2023, 13(9): 1328.
|
| [17] |
WEI Q, ZHUANG X, FAN J, et al. Proinflammatory and angiogenesis-related cytokines in vitreous samples of highly myopic patients[J]. Cytokine, 2021, 137: 155308.
|
| [18] |
NISHANTH S, BAUER N J C, SHETTY R, et al. A novel comparative study of inflammatory cytokines through noninvasive tear analysis in children with myopia versus emmetropia[J]. Am J Ophthalmol, 2025, 278: 413-420.
|
| [19] |
LIANG R, LI T, GAO H, et al. Causal relationships between inflammatory cytokines and myopia: an analysis of genetic and observational studies[J]. Ann Med Surg, 2024, 86(9): 5179-5190.
|
| [20] |
MCBRIEN N A. Regulation of scleral metabolism in myopia and the role of transforming growth factor-beta[J]. Exp Eye Res, 2013, 114: 128-140.
|
| [21] |
YU Q, ZHOU J B. Scleral remodeling in myopia development[J]. Int J Ophthalmol, 2022, 15(3): 510-514.
|
| [22] |
ZHAO F, ZHOU Q, REINACH P S, et al. Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and myopia development in mice[J]. Am J Pathol, 2018, 188(8): 1754-1767.
|
| [23] |
IKEDA S I, KURIHARA T, TODA M, et al. Oral bovine milk lactoferrin administration suppressed myopia development through matrix metalloproteinase 2 in a mouse model[J]. Nutrients, 2020, 12(12). DOI: 10.3390/nu12123744.
|
| [24] |
LIU L, ZHOU W, FAN Y, et al. Effect of interleukin 6 on scleral fibroblast proliferation, differentiation, and apoptosis involved in myopic scleral remodeling[J]. Ophthalmic Res, 2022, 65(5): 529-539.
|
| [25] |
KU H, CHEN J J, HU M, et al. Myopia development in tree shrew is associated with chronic inflammatory reactions[J]. Curr Issues Mol Biol, 2022, 44(9): 4303-4313.
|
| [26] |
KU H, CHEN J J, CHEN W, et al. The role of transforming growth factor beta in myopia development[J]. Mol Immunol, 2024, 167: 34-42.
|
| [27] |
CHEN Z, XIAO K, LONG Q. Up-regulation of NLRP3 in the sclera correlates with myopia progression in a form-deprivation myopia mouse model[J]. Front Biosci, 2023, 28(2): 27.
|
| [28] |
XIAO K, CHEN Z, HE S, et al. Up-regulation of scleral C5b-9 and its regulation of the NLRP3 inflammasome in a form-deprivation myopia mouse model[J]. Immunobiology, 2024, 229(1): 152776.
|
| [29] |
CHOU Y L, HSU Y A, LIN C F, et al. Complement decay-accelerating factor inhibits inflammation-induced myopia development[J]. Mol Immunol, 2024, 171: 47-55.
|
| [30] |
CHEN C S, HSU Y A, LIN C H, et al. Fallopia Japonica and Prunella vulgaris inhibit myopia progression by suppressing AKT and NFκB mediated inflammatory reactions[J]. BMC Complement Med Ther, 2022, 22(1): 271.
|
| [31] |
HSU Y A, CHEN C S, WANG Y C, et al. Anti-inflammatory effects of resveratrol on human retinal pigment cells and a myopia animal model[J]. Curr Issues Mol Biol, 2021, 43(2): 716-727.
|
| [32] |
TIEN P T, LIN C H, CHEN C S, et al. Diacerein inhibits myopia progression through lowering inflammation in retinal pigment epithelial cell[J]. Mediators Inflamm, 2021, 2021: 6660640.
|